Report overview
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
This report contains market size and forecasts of Human Immunodeficiency Virus (HIV) in Global, including the following market information:
Global Human Immunodeficiency Virus (HIV) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Human Immunodeficiency Virus (HIV) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Immunodeficiency Virus (HIV) include Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Bristol-Myers Squibb, Boehringer Ingelheim, Genentech and Cipla. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Immunodeficiency Virus (HIV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Immunodeficiency Virus (HIV) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Human Immunodeficiency Virus (HIV) Market Segment Percentages, by Type, 2021 (%)
Diagnosis
Treatment
Global Human Immunodeficiency Virus (HIV) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Human Immunodeficiency Virus (HIV) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Others
Global Human Immunodeficiency Virus (HIV) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Human Immunodeficiency Virus (HIV) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Immunodeficiency Virus (HIV) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Human Immunodeficiency Virus (HIV) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bristol-Myers Squibb
Boehringer Ingelheim
Genentech
Cipla
